BVMF/V2EE34 (BVMF/V2EE34)

Brazil Stock Exchange: BVMF/V2EE34 · BRL

R$56.4

-0.71 (-1.2%)· Recorded snapshot

Market cap	276.5B
Revenue (ttm)	17.6B
Net income (ttm)	5.2B
EPS (ttm)	R$1.09
P/E (trailing)	51.9x
P/E (forward)	32.3x
Volume	75
Beta	0.93

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.6B
Net income (ttm): 5.2B
EPS (ttm): R$1.09
P/E (trailing): 51.9x
P/E (forward): 32.3x
Market cap: 276.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E32.3

P25 n/aP50 n/aP75 n/a

Trailing P/E51.9

P25 n/aP50 n/aP75 n/a

ROE14.4

P25 n/aP50 n/aP75 n/a

ROIC95.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All BVMF/V2EE34 indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-12-02
Employees	7,928
Employees change	637
Employees growth	8.74%
Enterprise value	BRL 238.4B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-07-12
Fiscal year end	January
Founded	2007
Industry	Health Information Services
Is primary listing	No
ISIN number	BRV2EEBDR000
Last earnings date	2026-08-26
Last refreshed	2026-10-29
Market cap	BRL 276.5B
Next earnings date	2026-12-02
Price	BRL 56.40
Price currency	BRL
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-28
Symbol	bvmf/V2EE34
Website	https://www.veeva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	71x
Average P/E ratio (3Y)	48.61x
Average P/E ratio (5Y)	58.65x
Earnings yield	1.93%
EV/Earnings	46.2x
EV/EBIT	42.87x
EV/EBITDA	40.5x
EV/FCF	28.61x
EV/Sales	12.83x
FCF / EV yield	3.5%
FCF yield	3.01%
Forward P/E	32.26x
Graham number	13.51128
Graham upside	-76.04%
Lynch fair value	BRL 20.05
Lynch upside	-64.44%
P/(FCF - SBC) ratio	47.52x
P/(OCF - SBC) ratio	46.44x
P/B ratio	7.32x
P/E ratio	51.86x
P/FCF ratio	33.18x
P/OCF ratio	32.65x
P/S ratio	15.72x
Price / tangible book value	7.9x
Price/EBITDA ratio	50.56x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.93%
EBITDA margin	31.1%
Effective tax rate	23.55%
FCF margin	45.05%
Gross margin	74.96%
Operating margin	29.93%
Pretax margin	38.38%
Profit margin	29.34%
Profit per employee	BRL 650,847
Profitable quarters	56
Profitable years	16
Revenue per employee	BRL 2.2M
ROA	7.58%
ROA (5Y)	6.94%
ROCE	13.61%
ROE	14.42%
ROE (5Y)	14.27%
ROIC	95.58%
ROIC (5Y)	72.98%
SBC / revenue	14.3%
Tax / revenue	9.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.52%
EPS growth (Q)	39.5%
EPS growth (QoQ)	5.73%
EPS growth 10Y	32.35%
EPS growth 3Y	22.48%
EPS growth 5Y	18.41%
EPS growth quarters	10
EPS growth years	14
FCF growth	23.4%
FCF growth (Q)	-0.62%
FCF growth (QoQ)	-79.5%
FCF growth 3Y	19.72%
FCF growth 5Y	16.93%
Gross profit growth	15.53%
Gross profit growth (Q)	17.2%
Gross profit growth 3Y	17.98%
Gross profit growth 5Y	16.49%
Net income growth	25.29%
Net income growth (Q)	36.5%
Net income growth (QoQ)	4.79%
Net income growth 3Y	23.39%
Net income growth 5Y	19.05%
Net income growth quarters	10
Net income growth years	15
OCF growth	23.44%
OCF growth (Q)	0.12%
OCF growth (QoQ)	-78.82%
OCF growth 10Y	27.71%
OCF growth 3Y	19.46%
OCF growth 5Y	16.95%
Operating income growth	24.68%
Operating income growth (Q)	21.4%
Operating income growth 3Y	37.75%
Operating income growth 5Y	17.95%
Revenue growth	16.5%
Revenue growth (Q)	17.6%
Revenue growth (QoQ)	5.1%
Revenue growth 10Y	22.03%
Revenue growth 3Y	15.71%
Revenue growth 5Y	15.76%
Revenue growth quarters	52
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -135.7M
Depreciation and amortization	BRL 216.5M
EBIT	BRL 5.3B
EBITDA	BRL 5.5B
EPS	BRL 1.09
Financing cash flow	BRL -3.4B
Free cash flow	BRL 8.3B
Free cash flow minus SBC	BRL 5.8B
Gross profit	BRL 13.2B
Income taxes	BRL 1.6B
Investing cash flow	BRL -5.7B
Net cash flow	BRL -601.5M
Net income	BRL 5.2B
Operating cash flow minus SBC	BRL 6B
Operating income	BRL 5.3B
Revenue	BRL 17.6B
Stock-based compensation	BRL 2.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	15.64
Book value per share	BRL 233.49
Debt / EBITDA	0.14
Debt / equity	0.02
Debt / FCF	0.09
Goodwill	BRL 2.6B
Long-term assets	BRL 3.6B
Long-term liabilities	BRL 495.1M
Net cash (debt)	BRL 36.1B
Net cash / market cap	13.04%
Net cash growth	12.23%
Net debt / EBITDA	-6.59
Net debt / equity	-0.95
Net debt / FCF	-4.33
Piotroski F-Score	4
Property, plant and equipment	BRL 1.1B
Shareholders' equity	BRL 37.8B
Tangible book value	BRL 35B
Tangible book value per share	BRL 216.26
Total assets	BRL 46.1B
Total cash	BRL 36.8B
Total debt	BRL 771.3M
Total liabilities	BRL 8.3B
WACC	9.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current assets	BRL 42.5B
Current liabilities	BRL 7.8B
Current ratio	5.46
Net working capital	BRL -3.8B
Quick ratio	5.36
Working capital	BRL 33B
Working capital turnover	2.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Shareholder yield	0.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 40.87
1D price change	-1.24%
1M price change	16.53%
1M total return	16.53%
1W price change	5.92%
1W total return	5.92%
1Y price change	6.82%
1Y return CAGR	6.82%
1Y total return	6.82%
20-day SMA	BRL 49.47
200-day SMA	BRL 42.72
3M price change	79.05%
3M total return	79.05%
3Y price change	74.07%
3Y return CAGR	20.29%
3Y total return	74.07%
50-day SMA	BRL 43.19
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 57.11
52-week high date	2026-10-26
52-week low	BRL 25.14
52-week low date	2026-04-10
5Y price change	-6.16%
5Y return CAGR	-1.26%
5Y total return	-6.16%
6M price change	109.28%
6M total return	109.28%
All-time high	BRL 62.20
All-time high date	2021-10-22
All-time low	BRL 25.14
All-time low date	2026-04-10
Average true range (ATR)	BRL 1.45
Average volume	2.4K
Beta (5Y)	0.93
Change from 52-week high	-1.24%
Change from 52-week low	124.34%
Change from all-time high	-9.32%
Change from all-time low	124.34%
Change from open	0%
Day's gap	-1.24%
Dollar volume	BRL 4,230
High price	BRL 56.40
Low price	BRL 56.40
Monthly RSI	63.91
Open price	BRL 56.40
Previous close	BRL 57.11
Price vs 150-day SMA	37.99%
Price vs 20-day SMA	14%
Price vs 200-day SMA	32.02%
Price vs 50-day SMA	30.58%
Relative volume	0.03
RSI	72.95
Sharpe ratio	1.27
Sortino ratio	2.15
Volume	75
Weekly RSI	66.23
YTD price change	36.5%
YTD total return	36.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	148.3M
Shares change (QoQ)	-0.56%
Shares change (YoY)	-0.14%
Shares held by insiders	8.32%
Shares held by institutions	90.53%
Short ratio	2.5 days

Deeper analysis on BVMF/V2EE34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BVMF/V2EE34 report

Is a complete BVMF/V2EE34 research report available?

No complete published report is available for bvmf/V2EE34 (BVMF/V2EE34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

276.5B

Revenue (ttm)

17.6B

Net income (ttm)

5.2B

EPS (ttm)

R$1.09

P/E (trailing)

51.9x

P/E (forward)

32.3x

Volume

Beta

0.93

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-12-02

Employees

7,928

Employees change

637

Employees growth

8.74%

Enterprise value

BRL 238.4B

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-07-31

First seen

2026-07-12

Fiscal year end

January

Founded

2007

Industry

Health Information Services

Is primary listing

ISIN number

BRV2EEBDR000

Last earnings date

2026-08-26

Last refreshed

2026-10-29

Market cap

BRL 276.5B

Next earnings date

2026-12-02

Price

BRL 56.40

Price currency

BRL

Sector

Healthcare

SIC code

7370

Stock price date

2026-10-28

Symbol

bvmf/V2EE34

Website

https://www.veeva.com

Metric

Value

Average P/E ratio (10Y)

71x

Average P/E ratio (3Y)

48.61x

Average P/E ratio (5Y)

58.65x

Earnings yield

1.93%

EV/Earnings

46.2x

EV/EBIT

42.87x

EV/EBITDA

40.5x

EV/FCF

28.61x

EV/Sales

12.83x

FCF / EV yield

3.5%

FCF yield

3.01%

Forward P/E

32.26x

Graham number

13.51128

Graham upside

-76.04%

Lynch fair value

BRL 20.05

Lynch upside

-64.44%

P/(FCF - SBC) ratio

47.52x

P/(OCF - SBC) ratio

46.44x

P/B ratio

7.32x

P/E ratio

51.86x

P/FCF ratio

33.18x

P/OCF ratio

32.65x

P/S ratio

15.72x

Price / tangible book value

7.9x

Price/EBITDA ratio

50.56x

Sector forward P/E

11.05x

Sector P/E

41.08x

Metric

Value

EBIT margin

29.93%

EBITDA margin

31.1%

Effective tax rate

23.55%

FCF margin

45.05%

Gross margin

74.96%

Operating margin

29.93%

Pretax margin

38.38%

Profit margin

29.34%

Profit per employee

BRL 650,847

Profitable quarters

Profitable years

Revenue per employee

BRL 2.2M

ROA

7.58%

ROA (5Y)

6.94%

ROCE

13.61%

ROE

14.42%

ROE (5Y)

14.27%

ROIC

95.58%

ROIC (5Y)

72.98%

SBC / revenue

14.3%

Tax / revenue

9.04%

Metric

Value

EPS growth

25.52%

EPS growth (Q)

39.5%

EPS growth (QoQ)

5.73%

EPS growth 10Y

32.35%

EPS growth 3Y

22.48%

EPS growth 5Y

18.41%

EPS growth quarters

EPS growth years

FCF growth

23.4%

FCF growth (Q)

-0.62%

FCF growth (QoQ)

-79.5%

FCF growth 3Y

19.72%

FCF growth 5Y

16.93%

Gross profit growth

15.53%

Gross profit growth (Q)

17.2%

Gross profit growth 3Y

17.98%

Gross profit growth 5Y

16.49%

Net income growth

25.29%

Net income growth (Q)

36.5%

Net income growth (QoQ)

4.79%

Net income growth 3Y

23.39%

Net income growth 5Y

19.05%

Net income growth quarters

Net income growth years

OCF growth

23.44%

OCF growth (Q)

0.12%

OCF growth (QoQ)

-78.82%

OCF growth 10Y

27.71%

OCF growth 3Y

19.46%

OCF growth 5Y

16.95%

Operating income growth

24.68%

Operating income growth (Q)

21.4%

Operating income growth 3Y

37.75%

Operating income growth 5Y

17.95%

Revenue growth

16.5%

Revenue growth (Q)

17.6%

Revenue growth (QoQ)

5.1%

Revenue growth 10Y

22.03%

Revenue growth 3Y

15.71%

Revenue growth 5Y

15.76%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

BRL -135.7M

Depreciation and amortization

BRL 216.5M

EBIT

BRL 5.3B

EBITDA

BRL 5.5B

EPS

BRL 1.09

Financing cash flow

BRL -3.4B

Free cash flow

BRL 8.3B

Free cash flow minus SBC

BRL 5.8B

Gross profit

BRL 13.2B

Income taxes

BRL 1.6B

Investing cash flow

BRL -5.7B

Net cash flow

BRL -601.5M

Net income

BRL 5.2B

Operating cash flow minus SBC

BRL 6B

Operating income

BRL 5.3B

Revenue

BRL 17.6B

Stock-based compensation

BRL 2.5B

Metric

Value

Altman Z-Score

15.64

Book value per share

BRL 233.49

Debt / EBITDA

0.14

Debt / equity

0.02

Debt / FCF

0.09

Goodwill

BRL 2.6B

Long-term assets

BRL 3.6B

Long-term liabilities

BRL 495.1M

Net cash (debt)

BRL 36.1B

Net cash / market cap

13.04%

Net cash growth

12.23%

Net debt / EBITDA

-6.59

Net debt / equity

-0.95

Net debt / FCF

-4.33

Piotroski F-Score

Property, plant and equipment

BRL 1.1B

Shareholders' equity

BRL 37.8B

Tangible book value

BRL 35B

Tangible book value per share

BRL 216.26

Total assets

BRL 46.1B

Total cash

BRL 36.8B

Total debt

BRL 771.3M

Total liabilities

BRL 8.3B

WACC

9.36%

Metric

Value

Asset turnover

0.41

Current assets

BRL 42.5B

Current liabilities

BRL 7.8B

Current ratio

5.46

Net working capital

BRL -3.8B

Quick ratio

5.36

Working capital

BRL 33B

Working capital turnover

2.88

Metric

Value

Buyback yield / dilution

0.14%

Shareholder yield

0.14%

Metric

Value

150-day SMA

BRL 40.87

1D price change

-1.24%

1M price change

16.53%

1M total return

16.53%

1W price change

5.92%

1W total return

5.92%

1Y price change

6.82%

1Y return CAGR

6.82%

1Y total return

6.82%

20-day SMA

BRL 49.47

200-day SMA

BRL 42.72

3M price change

79.05%

3M total return

79.05%

3Y price change

74.07%

3Y return CAGR

20.29%

3Y total return

74.07%

50-day SMA

BRL 43.19

50-day SMA vs 200-day SMA

50over200

52-week high

BRL 57.11

52-week high date

2026-10-26

52-week low

BRL 25.14

52-week low date

2026-04-10

5Y price change

-6.16%

5Y return CAGR

-1.26%

5Y total return

-6.16%

6M price change

109.28%

6M total return

109.28%

All-time high

BRL 62.20

All-time high date

2021-10-22

All-time low

BRL 25.14

All-time low date

2026-04-10

Average true range (ATR)

BRL 1.45

Average volume

2.4K

Beta (5Y)

0.93

Change from 52-week high

-1.24%

Change from 52-week low

124.34%

Change from all-time high

-9.32%

Change from all-time low

124.34%

Change from open

Day's gap

-1.24%

Dollar volume

BRL 4,230

High price

BRL 56.40

Low price

BRL 56.40

Monthly RSI

63.91

Open price

BRL 56.40

Previous close

BRL 57.11

Price vs 150-day SMA

37.99%

Price vs 20-day SMA

14%

Price vs 200-day SMA

32.02%

Price vs 50-day SMA

30.58%

Relative volume

0.03

RSI

72.95

Sharpe ratio

1.27

Sortino ratio

2.15

Volume

Weekly RSI

66.23

YTD price change

36.5%

YTD total return

36.5%

Metric

Value

Float

148.3M

Shares change (QoQ)

-0.56%

Shares change (YoY)

-0.14%

Shares held by insiders

8.32%

Shares held by institutions

90.53%

Short ratio

2.5 days

BVMF/V2EE34 (BVMF/V2EE34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/V2EE34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/V2EE34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/V2EE34

Frequently asked questions

BVMF/V2EE34 (BVMF/V2EE34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/V2EE34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/V2EE34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/V2EE34

Frequently asked questions